Answers are grounded in this paper and cite their sources.
Wnt signaling regulates development, stem-cell maintenance, tissue homeostasis, and regeneration, making controlled pathway activation attractive for regenerative medicine. Canonical Wnt/β-catenin signaling is initiated by coordinated engagement of Frizzled (FZD) receptors and LRP5/6 co-receptors, followed by assembly of membrane-proximal signaling complexes that stabilize β-catenin. Native Wnt proteins, however, are challenging therapeutic agents because lipid modification limits solubility and manufacturing, while extensive ligand–receptor cross-reactivity constrains receptor selectivity. These limitations have motivated the development of synthetic agonists that activate the pathway by engineering receptor interactions directly. Early bispecific and multivalent agonists established that enforced FZD–LRP association can reproduce canonical signaling and support organoid growth and tissue regeneration. More recent structural and biophysical studies, however, indicate that receptor proximity alone is not always sufficient for productive signaling and highlight receptor identity, valency, stoichiometry, geometry, and higher-order clustering as important determinants of signaling output. In this Review, we organize recent advances around the mechanistic relationship between receptor architecture and signaling competence, with particular emphasis on receptor identity, valency, stoichiometry, geometry, and higher-order clustering. We further discuss alternative strategies involving Norrin and R-spondin engineering, approaches for spatial, temporal, and cell-selective pathway control, and the implications of these principles for regenerative medicine and therapeutic safety.
No takes yet. Share an insight, caveat, or question.
Gao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: